GLP-1 Receptor Agonists Linked to Depression and Suicidal Ideation
A groundbreaking study published in the journal Current Neuropharmacology has revealed a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists, widely used in blockbuster drugs like Ozempic, and the risk of depression and suicidal ideation. The research, led by an international team of 24 researchers, found genetic pathways that may induce depressive phenotypes in … Read more